196 related articles for article (PubMed ID: 38118413)
21. A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells.
Brekker MA; Sartawi T; Sawatzky TM; Causey CP; Rehman FK; Knuckley B
J Biol Chem; 2022 Aug; 298(8):102205. PubMed ID: 35764172
[TBL] [Abstract][Full Text] [Related]
22. PRMT1 loss sensitizes cells to PRMT5 inhibition.
Gao G; Zhang L; Villarreal OD; He W; Su D; Bedford E; Moh P; Shen J; Shi X; Bedford MT; Xu H
Nucleic Acids Res; 2019 Jun; 47(10):5038-5048. PubMed ID: 30916320
[TBL] [Abstract][Full Text] [Related]
23. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Al-Hamashi AA; Diaz K; Huang R
Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
[TBL] [Abstract][Full Text] [Related]
24. Arginine Methylation: The Coming of Age.
Blanc RS; Richard S
Mol Cell; 2017 Jan; 65(1):8-24. PubMed ID: 28061334
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Fedoriw A; Shi L; O'Brien S; Smitheman KN; Wang Y; Hou J; Sherk C; Rajapurkar S; Laraio J; Williams LJ; Xu C; Han G; Feng Q; Bedford MT; Wang L; Barbash O; Kruger RG; Hwu P; Mohammad HP; Peng W
Cancer Immunol Res; 2022 Apr; 10(4):420-436. PubMed ID: 35181787
[TBL] [Abstract][Full Text] [Related]
26. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
27. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions.
Lowe TL; Clarke SG
J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559
[TBL] [Abstract][Full Text] [Related]
28. Proteomics profiling of arginine methylation defines PRMT5 substrate specificity.
Musiani D; Bok J; Massignani E; Wu L; Tabaglio T; Ippolito MR; Cuomo A; Ozbek U; Zorgati H; Ghoshdastider U; Robinson RC; Guccione E; Bonaldi T
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940768
[TBL] [Abstract][Full Text] [Related]
29. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
[TBL] [Abstract][Full Text] [Related]
30. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain.
Frankel A; Clarke S
J Biol Chem; 2000 Oct; 275(42):32974-82. PubMed ID: 10931850
[TBL] [Abstract][Full Text] [Related]
31. Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.
Kölbel K; Ihling C; Bellmann-Sickert K; Neundorf I; Beck-Sickinger AG; Sinz A; Kühn U; Wahle E
J Biol Chem; 2009 Mar; 284(13):8274-82. PubMed ID: 19158082
[TBL] [Abstract][Full Text] [Related]
32. Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
Ma M; Liu F; Miles HN; Kim EJ; Fields L; Xu W; Li L
J Am Soc Mass Spectrom; 2023 Aug; 34(8):1692-1700. PubMed ID: 37463068
[TBL] [Abstract][Full Text] [Related]
33. PRMT1 and PRMT4 Regulate Oxidative Stress-Induced Retinal Pigment Epithelial Cell Damage in SIRT1-Dependent and SIRT1-Independent Manners.
Kim DI; Park MJ; Choi JH; Kim IS; Han HJ; Yoon KC; Park SW; Lee MY; Oh KS; Park SH
Oxid Med Cell Longev; 2015; 2015():617919. PubMed ID: 26583059
[TBL] [Abstract][Full Text] [Related]
34. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4.
Boulanger MC; Miranda TB; Clarke S; Di Fruscio M; Suter B; Lasko P; Richard S
Biochem J; 2004 Apr; 379(Pt 2):283-9. PubMed ID: 14705965
[TBL] [Abstract][Full Text] [Related]
36. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
Fulton MD; Dang T; Brown T; Zheng YG
Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
[TBL] [Abstract][Full Text] [Related]
37. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H; Qian K; Ho MC; Zheng YG
Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
[TBL] [Abstract][Full Text] [Related]
38. PRMT5 Facilitates Infectious Bursal Disease Virus Replication through Arginine Methylation of VP1.
Hu X; Chen Z; Wu X; Fu Q; Chen Z; Huang Y; Wu H
J Virol; 2023 Mar; 97(3):e0163722. PubMed ID: 36786602
[TBL] [Abstract][Full Text] [Related]
39. Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.
Zhang B; Zhang S; Zhu L; Chen X; Zhao Y; Chao L; Zhou J; Wang X; Zhang X; Ma N
Toxicol Appl Pharmacol; 2017 Dec; 336():1-7. PubMed ID: 28987382
[TBL] [Abstract][Full Text] [Related]
40. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
